Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of $110.46 billion as of November 21, 2024. Its market cap has increased by 9.97% in one year.

Market Cap

110.46B

Enterprise Value

126.92B

1-Year Change

9.97%

Ranking

#114

Market Cap Chart

Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $110.46B, an increase of 11,251.00%. That is a compound annual growth rate of 19.97%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	110.46B	9.43%
Dec 29, 2023	100.94B	-6.25%
Dec 30, 2022	107.68B	18.22%
Dec 31, 2021	91.08B	24.72%
Dec 31, 2020	73.03B	-11.17%
Dec 31, 2019	82.21B	1.60%
Dec 31, 2018	80.92B	-13.53%
Dec 29, 2017	93.58B	-0.81%
Dec 30, 2016	94.34B	-35.31%
Dec 31, 2015	145.83B	2.55%
Dec 31, 2014	142.21B	23.49%
Dec 31, 2013	115.15B	106.93%
Dec 31, 2012	55.65B	81.01%
Dec 30, 2011	30.74B	4.49%
Dec 31, 2010	29.42B	-24.44%
Dec 31, 2009	38.94B	-16.37%
Dec 31, 2008	46.56B	8.73%
Dec 31, 2007	42.82B	43.43%
Dec 29, 2006	29.86B	24.03%
Dec 30, 2005	24.07B	58.92%
Dec 31, 2004	15.15B	28.36%
Dec 31, 2003	11.80B	76.49%
Dec 31, 2002	6.69B	6.07%
Dec 31, 2001	6.30B	61.59%
Dec 29, 2000	3.90B	64.05%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Pfizer	140.46B
Boston Scientific	132.14B
Sanofi	121.20B
Vertex Pharmaceuticals	118.51B
Bristol-Myers Squibb Company	116.18B
Medtronic	108.99B
Elevance Health	92.20B
The Cigna Group	89.87B

Market Cap Rankings